Methods for repairing and regenerating human dura mater
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-035/12
C12N-011/02
A61L-027/36
A61L-027/24
출원번호
US-0291336
(2005-12-01)
등록번호
US-8834864
(2014-09-16)
발명자
/ 주소
Odar, Johann
Sepehrnia, Abolghassem
Schachtler, Ralph
Stemberger, Axel W.
출원인 / 주소
Baxter International Inc.
대리인 / 주소
Kilpatrick Townsend & Stockton LLP
인용정보
피인용 횟수 :
12인용 특허 :
119
초록▼
A method of using a substantially non-porous equine collagen foil to repair and regenerate dura mater tissue of mammals when the dura mater tissue is damaged as a result of injury, tumors, surgery, and the like. The non-porous equine collagen foil comprises collagen fibrils which provides a replacem
A method of using a substantially non-porous equine collagen foil to repair and regenerate dura mater tissue of mammals when the dura mater tissue is damaged as a result of injury, tumors, surgery, and the like. The non-porous equine collagen foil comprises collagen fibrils which provides a replacement dura mater composition that is elastic, liquid-tight, and which has a high tensile strength. The non-porous equine collagen foil is furthermore resorbable and provides a biomatrix, wherein a neodura is rapidly formed which becomes indistinguishable from the autologous dura mater in a matter of weeks. The process for making the equine collagen foil reduces the likelihood of disease transmission.
대표청구항▼
1. A method of repairing and regenerating dura mater tissue in a mammal comprising attaching a collagen foil to the dura matter tissue, wherein the collagen foil comprises a non-naturally occurring biomatrix of multiple layers of precipitated collagen fibrils having a diameter of between 10 to 300 n
1. A method of repairing and regenerating dura mater tissue in a mammal comprising attaching a collagen foil to the dura matter tissue, wherein the collagen foil comprises a non-naturally occurring biomatrix of multiple layers of precipitated collagen fibrils having a diameter of between 10 to 300 nanometers that are not cross-linked by chemicals or radiation, wherein the biomatrix comprises pores that are isolated from one another and are not interconnected in a manner which traverses the collagen foil, wherein the multiple layers of precipitated collagen fibrils form stacked collagen fibril sheets packed tightly together with interstices there between, and wherein the multiple layers of precipitated collagen fibrils of the collagen foil have an ultimate tensile force of between 0.5 Newtons/cm-strip and 30 Newtons/cm-strip. 2. The method of claim 1, wherein the collagen foil is an equine collagen foil. 3. The method of claim 2, wherein the collagen fibrils are derived from tendons. 4. The method of claim 2, wherein the dura mater tissue is located in the cranium. 5. The method of claim 2, wherein the dura mater tissue is located in the spinal column. 6. The method of claim 2, wherein the attaching step comprises one or more methods selected from the group consisting of: attaching the collagen foil to the dura mater tissue with fibrin sealant, attaching the collagen foil to the dura mater tissue with tissue glue, attaching the collagen foil to the dura mater tissue with surgical sutures, attaching the collagen foil to the dura mater tissue utilizing pressure fitting techniques, and attaching the collagen foil to the dura mater tissue utilizing natural adhesion between the collagen foil and the dura matter tissue. 7. The method of claim 2, wherein the collagen foil is substantially liquid tight. 8. The method of claim 2, wherein the collagen foil does not adhere to neural tissue or brain tissue after cell organization of the collagen foil with meningeal cells. 9. The method of claim 2, wherein the collagen foil does not adhere to the skull or spinal column tissue after cell organization of the collagen foil with meningeal cells. 10. The method of claim 2, wherein the mammal is selected from the group consisting of humans, horses, sheep, monkeys, and laboratory animals. 11. The method of claim 2, wherein the collagen foil further comprises an excipient selected from the group consisting of a preservative, a growth factor, an additive that aids in the flexibility and elasticity of the collagen foil, and combinations thereof. 12. A method of repairing and regenerating dura mater tissue in a mammal comprising attaching a collagen foil to the dura matter tissue, wherein the collagen foil comprises a non-naturally occurring biomatrix of multiple layers of precipitated collagen fibrils, wherein the biomatrix comprises pores that are isolated from one another and are not interconnected in a manner which traverses the collagen foil, wherein the multiple layers of precipitated collagen fibrils form stacked collagen fibril sheets packed tightly together with interstices there between, and wherein the multiple layers of precipitated collagen fibrils of the collagen foil have an ultimate tensile force of between 0.5 Newtons/cm-strip and 30 Newtons/cm-strip. 13. The method of claim 12, wherein the multiple layers of precipitated collagen fibrils of the collagen foil have an ultimate tensile force of between 1 Newtons/cm-strip and 6 Newtons/cm-strip. 14. The method of claim 12, wherein the dura mater tissue is located in the cranium. 15. The method of claim 12, wherein the dura mater tissue is located in the spinal column. 16. The method of claim 12, wherein the attaching step comprises one or more methods selected from the group consisting of: attaching the collagen foil to the dura mater tissue with fibrin sealant, attaching the collagen foil to the dura mater tissue with tissue glue, attaching the collagen foil to the dura mater tissue with surgical sutures, attaching the collagen foil to the dura mater tissue utilizing pressure fitting techniques, and attaching the collagen foil to the dura mater tissue utilizing natural adhesion between the collagen foil and the dura matter tissue. 17. The method of claim 12, wherein the collagen foil is substantially liquid tight. 18. The method of claim 12, wherein the collagen foil does not adhere to neural tissue or brain tissue after cell organization of the collagen foil with meningeal cells. 19. The method of claim 12, wherein the collagen foil does not adhere to the skull or spinal column tissue after cell organization of the collagen foil with meningeal cells. 20. The method of claim 12, wherein the mammal is selected from the group consisting of humans, horses, sheep, monkeys, and laboratory animals. 21. The method of claim 12, wherein the collagen foil further comprises an excipient selected from the group consisting of a preservative, a growth factor, an additive that aids in the flexibility and elasticity of the collagen foil, and combinations thereof. 22. The method of claim 1, wherein the collagen foil, in its dry form, has a thickness of between 0.01 mm and 3.0 mm. 23. The method of claim 22, wherein the collagen foil, in its dry form, has a thickness of between 0.03 mm and 1.5 mm. 24. The method of claim 22, wherein the dura mater tissue is located in the cranium. 25. The method of claim 22, wherein the dura mater tissue is located in the spinal column. 26. The method of claim 22, wherein the attaching step comprises one or more methods selected from the group consisting of: attaching the collagen foil to the dura mater tissue with fibrin sealant, attaching the collagen foil to the dura mater tissue with tissue glue, attaching the collagen foil to the dura mater tissue with surgical sutures, attaching the collagen foil to the dura mater tissue utilizing pressure fitting techniques, and attaching the collagen foil to the dura mater tissue utilizing natural adhesion between the collagen foil and the dura matter tissue. 27. The method of claim 22, wherein the collagen foil is substantially liquid tight. 28. The method of claim 22, wherein the collagen foil does not adhere to neural tissue or brain tissue after cell organization of the collagen foil with meningeal cells. 29. The method of claim 22, wherein the collagen foil does not adhere to the skull or spinal column tissue after cell organization of the collagen foil with meningeal cells. 30. The method of claim 22, wherein the mammal is selected from the group consisting of humans, horses, sheep, monkeys, and laboratory animals. 31. The method of claim 22, wherein the collagen foil further comprises an excipient selected from the group consisting of a preservative, a growth factor, an additive that aids in the flexibility and elasticity of the collagen foil, and combinations thereof. 32. The method of claim 1, wherein the collagen foil, in its dry form, has a thickness of 1.0 mm or less. 33. The method of claim 32, wherein the dura mater tissue is located in the cranium. 34. The method of claim 32, wherein the dura mater tissue is located in the spinal column. 35. The method of claim 32, wherein the attaching step comprises one or more methods selected from the group consisting of: attaching the collagen foil to the dura mater tissue with fibrin sealant, attaching the collagen foil to the dura mater tissue with tissue glue, attaching the collagen foil to the dura mater tissue with surgical sutures, attaching the collagen foil to the dura mater tissue utilizing pressure fitting techniques, and attaching the collagen foil to the dura mater tissue utilizing natural adhesion between the collagen foil and the dura matter tissue. 36. The method of claim 32, wherein the collagen foil is substantially liquid tight. 37. The method of claim 32, wherein the collagen foil does not adhere to neural tissue or brain tissue after cell organization of the collagen foil with meningeal cells. 38. The method of claim 32, wherein the collagen foil does not adhere to the skull or spinal column tissue after cell organization of the collagen foil with meningeal cells. 39. The method of claim 32, wherein the mammal is selected from the group consisting of humans, horses, sheep, monkeys, and laboratory animals. 40. The method of claim 32, wherein the collagen foil further comprises an excipient selected from the group consisting of a preservative, a growth factor, an additive that aids in the flexibility and elasticity of the collagen foil, and combinations thereof. 41. The method of claim 1, wherein the collagen foil, when completely hydrated, weighs up to 10 times its dry weight. 42. The method of claim 41, wherein the collagen foil, when completely hydrated, weighs up to 5 times its dry weight. 43. The method of claim 41, wherein the dura mater tissue is located in the cranium. 44. The method of claim 41, wherein the dura mater tissue is located in the spinal column. 45. The method of claim 41, wherein the attaching step comprises one or more methods selected from the group consisting of: attaching the collagen foil to the dura mater tissue with fibrin sealant, attaching the collagen foil to the dura mater tissue with tissue glue, attaching the collagen foil to the dura mater tissue with surgical sutures, attaching the collagen foil to the dura mater tissue utilizing pressure fitting techniques, and attaching the collagen foil to the dura mater tissue utilizing natural adhesion between the collagen foil and the dura matter tissue. 46. The method of claim 41, wherein the collagen foil is substantially liquid tight. 47. The method of claim 41, wherein the collagen foil does not adhere to neural tissue or brain tissue after cell organization of the collagen foil with meningeal cells. 48. The method of claim 41, wherein the collagen foil does not adhere to the skull or spinal column tissue after cell organization of the collagen foil with meningeal cells. 49. The method of claim 41, wherein the mammal is selected from the group consisting of humans, horses, sheep, monkeys, and laboratory animals. 50. The method of claim 41, wherein the collagen foil further comprises an excipient selected from the group consisting of a preservative, a growth factor, an additive that aids in the flexibility and elasticity of the collagen foil, and combinations thereof. 51. The method of claim 1, wherein the surface area of the collagen foil, when completely hydrated, is between −5% to 10% greater than when in its dry form. 52. The method of claim 51, wherein the surface area of the collagen foil, when completely hydrated, is up to about 4 percent greater than when in its dry form. 53. The method of claim 51, wherein the dura mater tissue is located in the cranium. 54. The method of claim 51, wherein the dura mater tissue is located in the spinal column. 55. The method of claim 51, wherein the attaching step comprises one or more methods selected from the group consisting of: attaching the collagen foil to the dura mater tissue with fibrin sealant, attaching the collagen foil to the dura mater tissue with tissue glue, attaching the collagen foil to the dura mater tissue with surgical sutures, attaching the collagen foil to the dura mater tissue utilizing pressure fitting techniques, and attaching the collagen foil to the dura mater tissue utilizing natural adhesion between the collagen foil and the dura matter tissue. 56. The method of claim 51, wherein the collagen foil is substantially liquid tight. 57. The method of claim 51, wherein the collagen foil does not adhere to neural tissue or brain tissue after cell organization of the collagen foil with meningeal cells. 58. The method of claim 51, wherein the collagen foil does not adhere to the skull or spinal column tissue after cell organization of the collagen foil with meningeal cells. 59. The method of claim 51, wherein the mammal is selected from the group consisting of humans, horses, sheep, monkeys, and laboratory animals. 60. The method of claim 51, wherein the collagen foil further comprises an excipient selected from the group consisting of a preservative, a growth factor, an additive that aids in the flexibility and elasticity of the collagen foil, and combinations thereof. 61. The method of claim 1, wherein the thickness of the collagen foil, when completely hydrated, is about twice the thickness of its dry form. 62. The method of claim 61, wherein the dura mater tissue is located in the cranium. 63. The method of claim 61, wherein the dura mater tissue is located in the spinal column. 64. The method of claim 61, wherein the attaching step comprises one or more methods selected from the group consisting of: attaching the collagen foil to the dura mater tissue with fibrin sealant, attaching the collagen foil to the dura mater tissue with tissue glue, attaching the collagen foil to the dura mater tissue with surgical sutures, attaching the collagen foil to the dura mater tissue utilizing pressure fitting techniques, and attaching the collagen foil to the dura mater tissue utilizing natural adhesion between the collagen foil and the dura matter tissue. 65. The method of claim 61, wherein the collagen foil is substantially liquid tight. 66. The method of claim 61, wherein the collagen foil does not adhere to neural tissue or brain tissue after cell organization of the collagen foil with meningeal cells. 67. The method of claim 61, wherein the collagen foil does not adhere to the skull or spinal column tissue after cell organization of the collagen foil with meningeal cells. 68. The method of claim 61, wherein the mammal is selected from the group consisting of humans, horses, sheep, monkeys, and laboratory animals. 69. The method of claim 61, wherein the collagen foil further comprises an excipient selected from the group consisting of a preservative, a growth factor, an additive that aids in the flexibility and elasticity of the collagen foil, and combinations thereof. 70. A method of repairing and regenerating dura mater tissue in a mammal comprising contacting a collagen foil to the dura matter tissue and allowing the collagen foil to be held in place in a desired implantation site by a natural adhesion that occurs between the collagen foil and the dura mater tissues, wherein the collagen foil comprises a non-naturally occurring biomatrix of multiple layers of precipitated collagen fibrils, wherein the biomatrix comprises pores that are isolated from one another and are not interconnected in a manner which traverses the collagen foil, wherein the multiple layers of precipitated collagen fibrils form stacked collagen fibril sheets packed tightly together with interstices there between. 71. The method of claim 70, wherein the contacting step comprises attaching the collagen foil to the dura mater tissue with a fibrin sealant. 72. The method of claim 70, wherein the contacting step comprises attaching the collagen foil to the dura mater tissue with a tissue glue. 73. The method of claim 70, wherein the contacting step comprises attaching the collagen foil to the dura mater tissue with surgical sutures. 74. The method of claim 70, wherein the contacting step comprises utilizing natural adhesion between the collagen foil and the dura mater tissue. 75. The method of claim 1, wherein the precipitated collagen fibrils are precipitated from a collagen suspension, and wherein the precipitation is caused at least in part due to raising the pH of the suspension. 76. The method of claim 1, wherein the collagen foil comprises a water content of between about 2% and 18% by weight. 77. The method of claim 1, wherein the collagen foil promotes cell and vasculature ingrowth across the foil through the interstices between the layers of collagen fibrils to form a neodura tissue in the mammal.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (119)
Kowanko Nicholas (618 S. Fifth St. Moorhead MN 56560), Adhesive composition and method.
Yeung Jeffrey E. (San Jose CA) Chu George H. (Cupertino CA) DeLustro Frank A. (Belmont CA) Rhee Woonza M. (Palo Alto CA), Anti-adhesion films and compositions for medical use.
Tay Sew-Wah (Plymouth MN) Schankereli Kemal (Stillwater MN) Holman Thomas (Minneapolis MN) Mische Hans (St. Cloud MN), Apparatus and method for sealing vascular punctures.
Tardy Michel (Lyons FRX) Tiollier Jerome (Lyons FRX) Tayot Jean-Louis (La Tour De Salvagny FRX), Biocompatible bioresorbable and non-toxic adhesive composition for surgical use.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Biologically inert, biocompatible-polymer conjugates.
Miyata Teruo (Tokyo NJ JPX) Rubin Albert L. (Englewood NJ) Stenzel Kurt H. (Englewood NJ) Dunn Michael W. (New Rochelle NY), Collagen drug delivery device.
Rhee Woonza M. (Palo Alto CA) Rao Prema R. (Los Gatos CA) Chu George H. (Cupertino CA) DeLustro Frank A. (Belmont CA) Harner Carol F. H. (Redwood Shores CA) Sakai Naomi (San Mateo CA) Schroeder Jacqu, Collagen-based bioadhesive compositions.
Silver Fred (Bangor PA) Sharma Vinay (Long Valley NJ) Berndt Dieter R. (Allenwood NJ) Marn Louis E. (Morris Plains NJ), Collagen-based wound dressing and method for applying same.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Henry Raymond L. (Grosse Pointe Woods MI), Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers an.
Palefsky Howard (Atherton CA) Pharriss Bruce B. (Palo Alto CA) Chu George (Cupertino CA), Composition of low type III content human placental collagen.
Olof Mikael Trollsas ; Donald G. Wallace ; Frank A. DeLustro, Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
Viegas Tacey X. (Ann Arbor MI) Reeve Lorraine E. (Dexter MI) Levinson Robert S. (Chesterfield MO), Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers.
Qian, Zhen; Osawa, A. Edward; Reich, Cary J.; Wallace, Donald G.; Shargill, Narinder S.; Vega, Felix, Dry hemostatic compositions and methods for their preparation.
Narotam Pradeep K.,CAX ; van Dellen James R.,ZAX ; O'Fee Robert P. ; McKinney ; III George W. ; Archibald Simon J. ; O'Grady Judith, Dural/meningeal repair product using collagen matrix.
Wallace Donald G. (Menlo Park CA) McMullin Hugh (Pacifica CA) Chu George (Cupertino CA), Injectable ceramic compositions and methods for their preparation and use.
Wallace Donald G. (Menlo Park) McMullin Hugh (Pacifica) Chu George (Cupertino CA), Injectable ceramic compositions and methods for their preparation and use.
Wallace Donald G. (Menlo Park CA) Reihanian Hertsel (San Francisco CA) Pharriss Bruce B. (Palo Alto CA) Braun William G. (Los Altos CA), Injectable implant composition having improved intrudability.
Etienne Schacht BE; An Van Den Bulcke BE; Bernard Delaey BE; Jean-Pierre Draye BE, Medicaments based on polymers composed of methacrylamide-modified gelatin.
Wahlig Helmut (Darmstadt DEX) Dingeldain Elvira (Dreieich DEX) Braun Dietrich (Darmstadt-Arheilgen DEX), Medicinally useful, shaped mass of collagen resorbable in the body.
Wahlig Helmut (Darmstadt DEX) Dingeldein Elvira (Dreieich DEX) Braun Dietrich (Darmstadt DEX), Medicinally useful, shaped mass of collagen resorbable in the body.
Goldberg Eugene P. (Gainesville FL) Yaacobi Yoseph (Gainesville FL), Method and composition for preventing surgical adhesions using a dilute solution of polymer.
Eibl Johann (Vienna ATX) Schwarz Otto (Vienna ATX) Elsinger Fritz (Vienna ATX) Wber Gnter (Oberwaltersdorf ATX) Philapitsch Anton (Ebenfurt ATX) Linnau Yendra (Vienna ATX) Dorner Friedrich (Vienna AT, Method of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood produc.
Sawyer Philip N. (Brooklyn NY) Sawyer Philip M. (Menlo Park CA) Reich Cary J. (Laguna Hills CA), Methods for sealing of staples and other fasteners in tissue.
Song Suk-Zu (Moorpark CA) Morawiecki Andrew (Camarillo CA) Pierce Glenn F. (Thousand Oaks CA) Pitt Colin G. (Westlake Village CA), Multi-layered collagen film compositions for delivery of proteins and methods of using same.
Saferstein Lowell (Edison NJ) Wolf Stephen (Neshanic Station NJ) Kamp Lola (Highland Park NJ) Linsky Cary (East Brunswick NJ) Wiseman David (Highland Park NJ), Process for preparing a neutralized oxidized cellulose product and its method of use.
Sharma Vinay K. (12 Walnut Dr. Long Valley NJ 07853), Process of preparing microparticulate collagen, collagen-based products thereby and method of applying same.
Wallace Donald G. ; Cruise Gregory M. ; Rhee Woonza M. ; Schroeder Jacqueline Anne ; Coker ; III George T. ; Maroney Marcee M., Rapid gelling biocompatible polymer composition.
Wallace, Donald G.; Cruise, Gregory M.; Rhee, Woonza M.; Schroeder, Jacqueline Anne; Coker, III, George T.; Maroney, Marcee M.; Trollsas, Olof Mikael, Rapid-gelling biocompatible polymer composition and associated methods of preparation and use.
Kensey Kenneth (Chester Springs PA) Nash John E. (Downington PA) Evans Douglas (Devon PA), System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Fort Lee NJ) Eaton Alexander M. (Durham NC), Tissue bonding and sealing composition and method of using the same.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Lido Beach NY) Eaton Alexander M. (New York NY), Tissue bonding and sealing composition and method of using the same.
Hermes Matthew E. (Easton CT) Muth Ross R. (Brookfield CT) Gustafson Darel L. (Shelton CT), Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin.
Weldon Thomas D. (P.O. Box 5149 Aquadilla PR 00605) Larsen Charles E. (P.O. Box 5149 Aquadilla PR 00605), Wound treating device using an inflatable membrane and method for treating wounds.
Lecuivre, Julie; Bourges, Xavier; Bailly, Pierre, Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.